The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Assertio (ASRT) is a stock that can certainly grab the attention ...

Assertio Holdings stock has fallen 8.15% since my updated bullish thesis in March 2023, while the S&P 500 Index has gained 4.95% over the same period. The SPPI deal is expected to give Assertio access ...

Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT) today announced that it has received confirmation from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained ...

In Q1 FY2023, Assertio achieved significant progress in executing the new strategy brought on board by CEO Dan Peisert. The market expects ASRT's EPS to decline nearly 82% YoY in FY2023, but then ...

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail ...

The world’s foremost artificial intelligence stock trading algorithm, An-E, predicts that Assertio (NASDAQ:ASRT) stock will gain 3% by June 1. An-E (pronounced Annie) has made this kind of prediction ...

Assertio Holdings (ASRT) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 11, 2024 for Q3.

Investors interested in Medical - Drugs stocks are likely familiar with Assertio (ASRT) and IPSEN SA ADR (IPSEY). But which of these two stocks offers value investors a better bang for their buck ...